To examine their possible relationship with imatinib resistance, the m6A modification level and KIAA1429 expression were measured in the K562 and KCL22 CML cell lines, as well as in the imatinib-resistant K562 cell line (K562/G01). The gene discussed is VIRMA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.